Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 242.2 - -
Change - -8.16% -23.89% -11.68% 52.89% 37.84% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 242.2 242.2 242.2
Change - -8.16% -23.89% -11.68% 52.89% 37.84% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.85x 0.76x 0.67x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.31x 0.3x 0.3x
EV / Revenue 0x 0x 0x 0x 0x 0.31x 0.3x 0.3x
EV / EBITDA 0x 0x 0x 0x 0x 2.12x 2.1x 2.1x
EV / EBIT 0x 0x 0x 0x 0x 3.9x 3.88x 3.86x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.78% 0.78% 0.78%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 5.100 5.100 5.100
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 30/03/22 31/03/23 27/03/24 28/03/25 27/03/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
12.4x0.39x8.06x3.12% 109B
14.3x1.8x9x0.73% 91.66B
-292.81x19.87x-343.85x-.--% 58.88B
13.37x1.47x8.89x2.67% 27.78B
22.74x2.54x12.9x1.43% 25.51B
21.86x2.02x11.6x0.96% 24.7B
30.99x5.59x23.23x2.25% 20.99B
7.71x1.4x6.37x-.--% 20.45B
30.1x2.82x12.71x1.49% 16.65B
Average -15.48x 4.21x -27.90x 1.41% 43.95B
Weighted average by Cap. -29.77x 4.36x -42.60x 1.55%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield